2024 Meta-Analysis Indicates That GLP-1RAs Reduce Adverse CV Events GLP1-RA therapy significantly reduces the risk of major adverse cardiovascular events (MACEs), all-cause mortality, CV mortality, stroke, risk for coronary revascularization, and composite adverse kidney outcomes in both sexes, regardless of a patient's history of cardiovascular disease, BMI or eGFR (Rivera et al, 2024)
This toll on our states health is also a toll on our economy, costing an estimated $10.7 billion a year, or nearly 2% of state GDP
Dont be afraid to introduce or include a food many timesthey might surprise you
The tank was sectioned into four equal quadrants that were defined as southeast, southwest, northwest, and northeast
Lancet (2006) 368(9548):1696705